review·Trends in Molecular Medicine·Feb 2, 2015GREEN OA

Cancer nanomedicine: from targeted delivery to combination therapy

XXXiaoyang XuCorresponding authorWHWilliam HoXZXueqing ZhangNBNicolas BertrandOCOmid C. Farokhzad

Massachusetts Institute of Technology · New Jersey Institute of Technology · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

686
total citations
FWCI
35.14
Percentile
100%
References
82
Citations per year

Authors

5
  • XX
    Xiaoyang XuCorresponding

    Massachusetts Institute of Technology, New Jersey Institute of Technology, Brigham and Women's Hospital, Harvard University

  • WH
    William Ho

    Harvard University, Brigham and Women's Hospital

  • XZ
    Xueqing Zhang

    Brigham and Women's Hospital, Harvard University

  • NB
    Nicolas Bertrand
  • OC
    Omid C. Farokhzad

    Brigham and Women's Hospital, Harvard University

Topics & keywords

Topics
  • Primary topicNanoparticle-Based Drug Delivery100%
  • Nanoplatforms for cancer theranostics100%
  • Graphene and Nanomaterials Applications100%
Keywords
  • Nanomedicine
  • Drug delivery
  • Cancer therapy
  • Cancer
  • Nanotechnology
  • Nanocarriers
  • Targeted drug delivery
  • Medicine
No related works found for this paper.

Funding

  • PC
    Prostate Cancer Foundation
  • NI
    National Institutes of Health
    Award: CA151884
  • CI
    Canadian Institutes of Health Research
  • NH
    National Heart, Lung, and Blood Institute
    Award: HHSN268201000045C